Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (3430)	12/26/1997 3:39:00 PM
From: STANLEY COHEN	Respond to of 6136

IZZY: EXCELLANT RESONSE. GO IZZY GO. STANLEY(BLINTZER)COHEN

To: Izzy who wrote (3430)	12/27/1997 12:04:00 AM
From: Mr. Pink	Read Replies (2) \| Respond to of 6136

Does anyone know what the current # of Viracept prescriptions sold per week is? How much does Agouron get paid on average per prescription? Is the rate of growth of new Viracept prescriptions still increasing exponentially? Finally, what is the cost of production per prescription? These #'s would go a long way towards getting some sort of a numerical handle on AGPH's prospects. Someone posted that the price of the stock might go to 60 over the next 12 months. I think predicting the earnings of AGPH 12 mos. from now would be more useful than guesstimating the stock price.

To: Izzy who wrote (3430)	12/27/1997 12:59:00 AM
From: Oliver & Co	Read Replies (1) \| Respond to of 6136

IAPAC Proposes Rationing HIV Drugs in the U.S." AIDS Alert (01/98) Vol. 13, No. 1, P. 9 ÿÿÿÿ The International Association of Physicians in AIDS Care in Chicago has announced its support for a policy to ration HIV/AIDS drugs in the United States. The group has proposed that a team of experts--composed of bioethicists, physicians, community leaders, health care officials, and people with HIV--work together on a plan for explicit rationing. Among the issues the panel would need to consider are how a patient's age, health, financial status, and ability to comply with drug regimens should factor into eligibility. Public health officials say that without rationing or a national mandate to increase HIV treatment funding dramatically, the cost of new therapies will remain prohibitive for a number of patients. Georgetown University law professor Lawrence Gostin notes that lotteries have been used to ration drugs in the past, citing instances when new therapies for the treatment of multiple sclerosis and Lou Gehrig's disease were first released.

To: Izzy who wrote (3430)	12/27/1997 1:03:00 AM
From: Oliver & Co	Respond to of 6136

IAPAC Proposes Rationing HIV Drugs in the U.S." AIDS Alert (01/98) Vol. 13, No. 1, P. 9 ÿÿÿÿ The International Association of Physicians in AIDS Care in Chicago has announced its support for a policy to ration HIV/AIDS drugs in the United States. The group has proposed that a team of experts--composed of bioethicists, physicians, community leaders, health care officials, and people with HIV--work together on a plan for explicit rationing. Among the issues the panel would need to consider are how a patient's age, health, financial status, and ability to comply with drug regimens should factor into eligibility. Public health officials say that without rationing or a national mandate to increase HIV treatment funding dramatically, the cost of new therapies will remain prohibitive for a number of patients. Georgetown University law professor Lawrence Gostin notes that lotteries have been used to ration drugs in the past, citing instances when new therapies for the treatment of multiple sclerosis and Lou Gehrig's disease were first released. ***************************************************************** The AIDSNews